LYFT vs PPCB · P/E 108, rev $5.79B vs P/E 0.0, $3.9M cap
LYFT Inc (LYFT) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
LYFT Inc (LYFT) is a software - application company listed on US. It is led by David Risher.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported LYFT revenue for 2024-12-31 was $5.79B. Net income was $22.8M. Revenue was up 31.4% from 2023-12-31 to 2024-12-31. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
PPCB does not have a complete income-statement cache yet.
LYFT currently screens at market cap $6.79B and trailing P/E 107.7. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the LYFT and PPCB stock pages for the full models.
Not investment advice.